Finance

Lists
Why is MDNA up 6,49%?
Dive Deeper
MDNA:TSE
Medicenna Therapeutics Corp
CAD 0,41
+6,49%
(+0,025) 1D
5 Okt., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDNA...
Open
CAD 0,38
High
CAD 0,42
Low
CAD 0,38
Mkt. cap
37,36 m
Avg. vol.
38,26 k
Volume
15,00 k
52-wk high
CAD 1,97
52-wk low
CAD 0,34
EPS
-CAD 0,22
Beta
1,77
Shares outstanding
92,30 m
No. of employees
15
Open
CAD 0,38
High
CAD 0,42
Low
CAD 0,38
Mkt. cap
37,36 m
Avg. vol.
38,26 k
Volume
15,00 k
52-wk high
CAD 1,97
52-wk low
CAD 0,34
EPS
-CAD 0,22
Beta
1,77
Shares outstanding
92,30 m
No. of employees
15
News stories
From web sources and news partners
About Medicenna Therapeutics Corp
CEO-
Employees15
Founded2015
HeadquartersToronto, Ontario, Kanada
Sector-
Websitemedicenna.com
Last report
04 Nov. 2022
Fiscal period
Q2 2023
EPS / Est. (CAD)
-CAD 0,07 / -CAD 0,07
-7,84%miss
Revenue / Est. (CAD)
- / 0,00
Fiscal Q2 2023 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,11 m
4,07 m
4,50 m
4,24 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,36 m
1,54 m
1,32 m
1,21 m
Operating expense
5,47 m
5,62 m
5,82 m
5,45 m
Total operating expenses
5,47 m
5,62 m
5,82 m
5,45 m
Operating income
-5,47 m
-5,62 m
-5,82 m
-5,45 m
Other non operating income
200,00 k
1,29 m
1,51 m
400,00 k
EBT including unusual items
-4,88 m
-4,36 m
-4,23 m
-5,08 m
EBT excluding unusual items
-4,88 m
-4,36 m
-4,23 m
-5,08 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,88 m
-4,36 m
-4,23 m
-5,08 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
158,00 k
114,00 k
53,00 k
25,00 k
Interest expense
-
-
-
-
Net interest expenses
158,00 k
114,00 k
53,00 k
25,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,46 m
-5,61 m
-5,82 m
-5,45 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme